Publications

Our Research

Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic review

BMJ Oncology

Abstract: Identification of tumor-marker gangliosides for early cancer detection: A multi-platform approach.

2024 American Society of Clinical Oncology (ASCO) meeting

Poster Presentation: Identification of Tumor-Marker Gangliosides for Early Cancer Detection: A Mass Spectrometry Approach

American Association for Cancer Research (AACR)

Poster Presentation: Identification of Tumor-Marker Gangliosides for Early Cancer Detection: A Multi-Platform Approach

2024 Glycolipid and Sphingolipid Biology Gordon Research Conference

The Cancer Glycocode as a Family of Diagnostic Biomarkers, Exemplified by Tumor-Associated Gangliosides

Frontiers in Oncology

Abstract: GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer

2023 American Society of Clinical Oncology (ASCO) meeting

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer

Frontiers in Oncology

Poster Presentation: GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies

2023 Society of Gynecologic Oncology Annual Meeting on Women's Cancer

Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malignancies

The Journal of Precision Medicine

GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies

2022 Early Detection of Cancer Conference

Aiming for the Sweet Spot: Glyco-Immune Checkpoints and gd T Cells in Targeted Immunotherapy

Frontiers in Immunology